Sepsis Current Affairs, GK & News

CSIR: Clinical Trial of “Sepsivac” drug on critically ill COVID-19 patients

On April 22, 2020, the Council of Scientific and Industrial Research announced that it is to go for clinical trials on critically ill COVID-19 patients. Background The Drugs Controller General of India recently approved the trial of “Sepsivac”. The drug is available commercially. With the DCGI approving the drug, CSIR is to start clinical trials ..

Month: 

Category: 

Topics: 

DCGI approves COVID-19 drug to reduce mortality rate

On April 20, 2020, the Drugs Controller General of India (DCGI) approved trial of a drug to reduce mortality rate of COVID-19 patients. Highlights The COVID-19 drug that was developed by the Cadila Pharmaceuticals along with Council of Scientific and Industrial Research (CSIR) is to enter into trial. The clinical trial has been approved by ..

Month: 

Category: 

Topics: 

Sepsis in COVID-19

Sepsis is a major cause of death world-wide even under normal circumstances. In light of the COVID-19 pandemic, the condition is claiming even more lives. Sepsis It is a medical condition where body’s immune system goes into an overdrive and causes tissue damage, multiple organ dysfunction and even death. It is triggered by infections. Every ..

Topics: 

Scientists discover new therapy to prevent sepsis in new born babies

A team of scientists from US have discovered an inexpensive prevention technique (therapy) against sepsis in new born babies. The team was led by US-based Indian doctor Dr Pinaki Panigrahi. The therapy has been found to reduce the risk of sepsis infection by 40% in trials and it can be inexpensive – less than one ..

Month: 

Topics: